CanaFarma Hemp Products Corp - Initiation
Last updated: 10:15 06 May 2020 EDT, First published: 10:13 06 May 2020 EDT
CanaFarma Hemp Products Corp. (CSE:CNFA, FRA:4K9) produces a range of hemp-derived products for the consumer wellness market. The company has a vertically integrated ‘farm-to-table’ strategy encompassing cultivation, extraction/process, manufacture of branded consumer products, and sales & marketing. Within the fast-growing market for hemp-based products (28% annual growth trend, see p4-5), CanaFarma is differentiated by a powerful and tested direct-to-consumer (DTC) marketing engine, and a product range that is scientifically validated and consistent quality.
Milestones delivered to date In 2019 CanaFarma cultivated a 55 acre licensed hemp growing site in New York state, producing 128k pounds (lbs) of hemp, and exceeding industry productivity benchmarks. The company is now seeking suitable sites for cultivation on the required scale to support its future operations. Also during 2019, the company achieved US$2.8mln of sales of consumer-branded products, at a peak run-rate of more than US$600k per month via its DTC marketing channels, using products manufactured for CanaFarma by a third party. The DTC marketing strategy is an important driver for the company, and the results achieved in 2019 give an indication of the potential revenue ramp-up going forward. |
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities,...
FOR OUR FULL DISCLAIMER CLICK HEREThis document is published by Proactive Research and its contents have not been approved as a financial promotion by Proactive Investors Limited or any other FCA authorised person. This communication is made on the basis of the 'journalist exemption' provide for in Article 20 of The Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and having regard to the FCA rules, and in particular PERG 8.12.
Where the note contains a ‘buy, sell, hold’ recommend, Proactive Investors Limited is authorised to provide investment advice as defined by Article 53 of the RAO
FOR OUR FULL DISCLAIMER CLICK HERE